Altesa BioSciences, Inc., 2026-02-23
An SEC Form D private-offering notice from College Park, GA, a $74,999,986 filer-stated offering target in Biotech. Filed 2026-02-23. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Clinical-stage pharmaceutical company developing vapendavir, an oral treatment for rhinovirus infections in patients with COPD and asthma.
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- IFS Group, Inc., 2026-03-05, $15M, Atlanta, GA
- Nasus Pharma Ltd, 2026-02-25, $15M, Tel Aviv
- Bitcoin Treasuries Media Inc., 2026-03-04, $80, Atlanta, GA
- NANOVIRICIDES, INC., 2026-02-25, $6M, Shelton, CT
- Online Camps Inc., 2026-02-27, $160K, Statesboro, GA
- Lonestar Medicines, Inc., 2026-02-23, $45M, Boston, MA
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.